Luse Rebecca reported LBRX

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0002031342-26-000002

Machine-readable

Structured copy

Timestamps

Event (reported)

Jun 3, 2026

Published

Jun 5, 2026

Ingested by INSIDER

Nov 5, 03:54 UTC

Last re-read

Nov 5, 03:54 UTC

Extracted facts

Filer

Luse Rebecca

Role

Director

Transaction

Grant or awardAs filed: “A”

Asset

LB PHARMACEUTICALS INC — Stock Option (Right to Buy)

Ticker

LBRX

Shares

10.0K

Price per share

$0

Execution date (reported)

Jun 3, 2026

Owned after transaction

10.0K shares

Days from execution to publication

2

What this establishes

Luse Rebecca filed this Form 4 reporting a grant or award of LBRX on Jun 3, 2026. It became public on Jun 5, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director

Luse Rebeccacik:0002031342

Issuer

LB PHARMACEUTICALS INCcik:0001691082

Revision history · 0

No field has changed since this record was first ingested.